Overview Fundamentals API Earnings EOD API Sample Code Pricing

Fusion Pharmaceuticals Inc (FUSN NASDAQ) stock market data APIs

$ (%) as of July 16, 2024
Price chart is built with Anychart

Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines in Canada and the United States. The company's lead product candidates include FPI-2265 that is in Phase 2 clinical trial to treat prostate-specific membrane antigens; and FPI-1434 that is in Phase 1 clinical trial as a monotherapy in patients with solid tumors expressing that target insulin-like growth factor 1 receptor. It is conducting additional preclinical studies of FPI-1434 in combination with approved checkpoint inhibitors and DNA damage response inhibitors to further assess the anti-tumor activity, and dosing schedule and pharmacodynamics of the combinations. In addition, the company develops FPI-1966 for the treatment of multiple cancers, including colorectal, ovarian, bladder, and head and neck cancers.; FPI-2068, a bispecific antibody, which is in Phase 1 clinical trial targeting epidermal growth factor receptor, and mesenchymal epithelial transition factor. It has a strategic collaboration agreement with AstraZeneca UK Limited to discover, develop, and commercialize alpha-emitting radiopharmaceuticals and combination therapies for the treatment of cancer. The company was incorporated in 2014 and is headquartered in Hamilton, Canada. As of June 4, 2024, Fusion Pharmaceuticals Inc. operates as a subsidiary of AstraZeneca AB.

Fusion Pharmaceuticals Inc Financial Data Overview

-
2.31-21.6
1 833 M
85 060 K
2 040 K
-0.4019
-0.692
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'FUSN',
Type: 'Common Stock',
Name: 'Fusion Pharmaceuticals Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00V9VQ3R9',
ISIN: 'CA36118A1003',
CUSIP: '449391101',
CIK: '1805890',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2016-03-14',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Fusion Pharmaceuticals Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 2 040 K
  • EBITDA -108 804 000
  • Earnings Per Share -1.4
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Fusion Pharmaceuticals Inc Earnings via APIs

  • Latest Release 2024-06-14
  • EPS/Forecast -0.37

Get Fusion Pharmaceuticals Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com